首页> 美国卫生研究院文献>other >Massachusetts Health Reform was Cost Saving for Individuals with New Venous Thromboembolism: A Cost-effectiveness Analysis

【2h】

Massachusetts Health Reform was Cost Saving for Individuals with New Venous Thromboembolism: A Cost-effectiveness Analysis

机译：马萨诸塞州医疗改革为患有新静脉血栓栓塞症的患者节省了成本：一项成本效益分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundPatients with venous thromboembolism (VTE) require access to comprehensive physician and pharmacy benefits to prevent recurrence and hemorrhage. Prior to 2006, Massachusetts provided these benefits through a program restricted to safety net hospitals called Free Care. Providing portable health insurance through Massachusetts health reform could improve outcomes for uninsured with VTE but its cost-effectiveness is unknown.

机译：背景患有静脉血栓栓塞症（VTE）的患者需要获得全面的医生和药房福利，以防止复发和出血。在2006年之前，马萨诸塞州通过仅限于安全网医院的一项名为“免费护理”的计划提供了这些好处。通过马萨诸塞州的医疗改革提供便携式医疗保险可以改善未接受VTE保险的人的结局，但其成本效益尚不清楚。

著录项

期刊名称 other
作者
Alok Kapoor; Nicholas Shaffer; Amresh Hanchate; Mark Roberts; Kenneth Smith;
展开▼
作者单位

展开▼
年(卷),期 -1(54),5
年度 -1
页码 474–482
总页数 18
原文格式 PDF
正文语种
中图分类
关键词
venous thromboembolism health reform health insurance;

机译：静脉血栓栓塞;健康改良;健康保险;

相似文献

外文文献
中文文献
专利

1. Massachusetts Health Reform Cost Less and Was More Effective for Uninsured Individuals With Venous Thromboembolism A Cost-Effectiveness Analysis [J] . Kapoor Alok, Shaffer Nicholas, Hanchate Amresh, Medical care . 2016,第5期

机译：马萨诸塞州医疗改革对患有静脉血栓栓塞的未参保个体的成本更低且更有效-成本-效果分析
2. Pharmaco-economics and decision making in health care. The case of “extended prophylaxis of venous thromboembolism with fondaparinux in patients undergoing major orthopaedic surgery in Italy: a cost-effectiveness analysis” [J] . Rosanna Tarricone Internal and Emergency Medicine . 2011,第6期

机译：药物经济学和卫生保健决策。 “意大利大型骨科手术患者用磺达肝癸钠预防静脉血栓栓塞的病例：成本-效果分析”
3. COST-EFFECTIVENESS OF VENOUS THROMBOEMBOLISM PROPHYLAXIS AFTER TOTAL KNEE AND HIP REPLACEMENT FROM THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM PERSPECTIVE [J] . Alexandre R. F., Santana C. F., Squiassi H. B., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017,第5期

机译：静脉血栓栓塞栓塞的成本效益预防总膝关节和巴西私立医疗系统视角下的膝盖和髋关节置换
4. Effectiveness of Evidence-Based Venous Thromboembolism Electronic Order Sets Measured by Health Outcomes [C] . Jacob Krive, Joei S.Shoolin, Steven D.Zink International Conference on Biomedical and Health Informatics . 2019

机译：通过健康成果测量的循证静脉血栓栓塞电子订单集的有效性
5. Cost-Effectiveness of Current Anticoagulation Care versus Genetic Testing of CYP2C9 and VKORC1 Prior to Long-Term Warfarin Anticoagulation Care: The Implementation of Discrete Event Simulation Model on the Natural History of Venous Thromboembolism. [D] . Teschemaker, Anna R. 2011

机译：当前抗凝治疗的成本效果与长期华法林抗凝治疗之前的CYP2C9和VKORC1遗传检测的关系：基于静脉血栓栓塞自然史的离散事件模拟模型的实现。
6. The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran [O] . Mohammadreza Amirsadri, Sarah Mousavi, Ali Karimipour 2019

机译：伊朗肝素对肝素血栓栓塞栓塞的使用与烯肝素的成本效益和成本实用性分析
7. PCV12 COST-EFFECTIVENESS ANALYSIS OF DABIGATRAN ETEXILATE VERSUS ENOXAPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP REPLACEMENT UNDER THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM PERSPECTIVE [O] . Fernandes RA, Quintella FF, Teich VD 2009

机译：在巴西公共卫生系统对全髋关节置换术后达比加群酯与依诺肝素预防静脉血栓形成的PCV12成本效益分析

Massachusetts Health Reform was Cost Saving for Individuals with New Venous Thromboembolism: A Cost-effectiveness Analysis

摘要

著录项

相似文献

相关主题

期刊订阅